Various cost-containment policies squeeze drug makers

In 2006, drug manufacturers and the National Health Insurance Corp. agreed to discuss the volume forecasts for a drug when it is first added to the reimbursement list.

After one year, stakeholders are to reconvene and adjust prices if the predicted volume is exceeded by a level of 30% in the first year of launching; 50 percent in the second year; 70 percent in the third year; 85 percent in ...